$541.91
0.46% day before yesterday
NYSE, Sep 06, 10:10 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$541.91
+18.23 3.48% 1M
+37.14 7.36% 6M
+70.35 14.92% YTD
+95.91 21.50% 1Y
+163.18 43.09% 3Y
+292.53 117.30% 5Y
+423.78 358.74% 10Y
NYSE, Closing price Fri, Sep 06 2024
-2.49 0.46%
ISIN
US0367521038
Symbol
ELV
Sector

Key metrics

Market capitalization $125.66b
Enterprise Value $146.96b
P/E (TTM) P/E ratio 19.00
EV/FCF (TTM) EV/FCF 179.22
EV/Sales (TTM) EV/Sales 0.86
P/S ratio (TTM) P/S ratio 0.73
P/B ratio (TTM) P/B ratio 2.98
Dividend yield 1.09%
Last dividend (FY23) $5.92
Revenue growth (TTM) Revenue growth 3.62%
Revenue (TTM) Revenue $171.72b
EBIT (operating result TTM) EBIT $9.40b
Free Cash Flow (TTM) Free Cash Flow $820.00m
EPS (TTM) EPS $28.52
P/E forward 15.30
P/S forward 0.73
EV/Sales forward 0.85
Short interest 0.72%
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

18x Buy
75%
6x Hold
25%

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

Buy
75%
Hold
25%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
171,719 171,719
4% 4%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 37,742 37,742
16% 16%
22%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 1,516 1,516
17% 17%
1%
EBIT (Operating Income) EBIT 9,403 9,403
1% 1%
5%
Net Profit 6,691 6,691
4% 4%
4%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Positive
Seeking Alpha
one day ago
Elevance Health has shown consistent earnings growth, with a 16% CAGR since 2014, and recent quarterly results exceeded expectations despite a slight revenue decline. The company's Carelon segment is a key growth driver, benefiting from cost savings and external revenue, with nearly 10% growth year-over-year. Elevance has a strong dividend growth history, with a 14.5% CAGR over the last decade,...
Neutral
Business Wire
24 days ago
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces it has reached its three-year, $90 million grant commitment to improve accessibility and further health equity across the country. Since July 2021, the Foundation has awarded $97.3 million in grants all toward programs that are improving maternal and child health, encouraging foo...
Positive
Seeking Alpha
about one month ago
The SPDR S&P 500 ETF Trust posted a 1.21% gain in July, underperforming Vanguard's Dividend Appreciation Index Fund ETF Shares by +3.97%. The top 15 dividend growth stocks for August 2024 offer an average dividend yield of 1.49% and appear to be about 28% undervalued based on dividend yield theory. Since its inception in September 2020, the watchlist has achieved a 12.25% annualized return.
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,900
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today